Long-term administration of beraprost, an oral prostacyclin analogue, improves pulmonary diffusion capacity in patients with systemic sclerosis-Reference-Cited by-同舟云学术

Long-term administration of beraprost, an oral prostacyclin analogue, improves pulmonary diffusion capacity in patients with systemic sclerosis

Published:2002-07 Issue:1 Volume:67 Page:45-49
ISSN:0952-3278
Container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids
language:en
Short-container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids

Author:

Matsukawa Y.,Saito O.,Aoki M.,Abe M.,Nishinarita S.,Sawada S.,Horie T.,Naruse S.,Hiranuma M.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry

Reference34 articles.

1. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine;Jimenez;J Rheumatol,1991

2. Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide;Akesson;Arthrit Rheum,1994

3. Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease;Silver;J Rheumatol,1993

4. Therapy for severe interstitial lung disease in systemic sclerosis;Steen;Arthrit Rheum,1994

5. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis;White;Ann Intern Med,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?;Current Opinion in Pulmonary Medicine;2023-07-14

2. RETRACTED ARTICLE: The clinical and laboratory features in Turkish systemic sclerosis patients: a single-center experience;Rheumatology International;2011-12-28

3. RETRACTED ARTICLE: Ten-year survival rates of methylprednisolone plus cyclophosphamide followed by mycophenolate mophetyl of azathiopurine for progressive systemic sclerosis patients;Rheumatology International;2011-11-19

4. Pulmonary Hypertension in Systemic Sclerosis;Seminars in Arthritis and Rheumatism;2011-08

5. Therapie bei systemischer Sklerodermie;Der Hautarzt;2007-09-13